P028 Treatment of BAFF Transgenic Mice With ANTI-TNF: Monoclonal ANTI-TNF Are Associated With a Higher Risk of Lymphoma Than Etanercept

doi 10.1136/annrheumdis-2018-ewrr2018.52
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

OP0307 Treatment of Baff Transgenic Mice With ANTI-TNF: Monoclonal ANTI-TNF Are Associated With a Higher Risk of Lymphoma Than Etanercept

2017English

Combination of Active and Passive Anti-TNF Treatments in Human-TNF Transgenic Mice

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

TNF Deficiency Fails to Protect BAFF Transgenic Mice Against Autoimmunity and Reveals a Predisposition to B Cell Lymphoma

Journal of Immunology
AllergyImmunology
2004English

Anti-Il-6 Receptor Antibody Causes Less Promotion of Tuberculosis Infection Than Anti-TNF- Antibody in Mice

Clinical and Developmental Immunology
2011English

Are Anti-TNF Drugs Safe for Pregnant Women With Inflammatory Bowel Disease?

Cleveland Clinic Journal of Medicine
Medicine
2018English

Humanization and Characterization of an Anti-Human TNF-α Murine Monoclonal Antibody

PLoS ONE
Multidisciplinary
2011English

TRAF1/C5 Locus Is Associated With Response to Anti-TNF in Rheumatoid Arthritis

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

AB1031 Anti-Drug Antibodies: Assay Performance in Patients Treated With ANTI-TNF Biodrugs

2017English

Microvascular Dysfunction in Ankylosing Spondylitis Is Associated With Disease Activity and Is Improved by Anti-TNF Treatment

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy